Meet the Team

OHE's exceptional team has strong expertise in the economics and statistics of health care provision and financing, the pricing and regulation of pharmaceuticals, and health technology assessment (HTA). Our experts have joined us from government, the life sciences industries, consultancies and academia. Supplementing our in-house expertise is an extensive network of health policy, economics and statistical experts based in the UK, Europe and around the world.

We emphasise activities that maintain the strength of our expertise, ensuring that both our research and consulting activities provide the best value possible. Each of our senior staff holds an academic appointment and we actively encourage our research and consultancy staff to publish and participate in conferences and seminars.

  • Adrian Towse

    Prof Adrian Towse


    Adrian’s current research includes the use of 'risk-sharing' arrangements between health care payers and pharmaceutical companies, including value-based pricing approaches; the economics of pharmacogenetics for health care payers and the pharmaceutical industry; economic issues that affect both R&D for and access to treatments for diseases prevalent in the developing world; the economics of medical negligence; and measuring productivity in health care.

    Read more

  • Jon Sussex

    Jon Sussex

    Deputy Director

    Jon’s areas of expertise include efficiency, competition, incentives and economic regulation in health care systems; the role of the private sector in publicly funded health care; the economic regulation of the pharmaceutical industry; and the economics of medical research. He leads many of the OHE’s projects in these areas.

    Read more

  • Nancy Devlin

    Prof Nancy Devlin

    Director of Research

    Nancy's principal areas of research expertise are the measurement and valuation of patient reported health outcomes; the cost effectiveness thresholds used in making judgments about value for money in health care; priority setting in health care; production, performance and efficiency of hospitals; and the determinants of patient choice.

    Read more

  • Jorge Mestre-Ferrandiz

    Jorge Mestre-Ferrandiz

    Director of Consulting

    Jorge's current research interests include pharmaceutical pricing and reimbursement systems worldwide, the economics of the pharmaceutical industry, the economics of innovation and incentives for encouraging medical R&D.

    Read more

  • Mike Herdman

    Michael Herdman

    Head of Health Outcomes

    Mike's current research interests are in the development, validation, application and use of patient-reported outcome (PRO) measures, analysis and interpretation of PRO data, techniques for obtaining health state preferences, and qualitative research consensus techniques in the development of PROs, the production of clinical guidelines, and priority-setting exercises in health care.

    Read more

  • Fraser Lewis

    Fraser Lewis

    Head of Statistics

    Fraser's principal areas of expertise are in statistical modelling of data from biomedical studies. His particular interests include methods of analyzing data from observational studies and graphical multivariate modelling.

    Read more

  • Amanda Chapman

    Amanda Chapman


    Amanda’s current research interests include health technology assessment for medical devices and the interaction between HTA policy and R&D decisions by industry.

    Read more

  • Lesley Baillie

    Lesley Cockcroft

    Assistant Statistician

    Lesley assists in the preparation and production of the OHE's health statistics website and publication by collecting and collating up-to-date material.

    Read more

  • Yan Feng

    Yan Feng

    Senior Researcher

    Yan's research interests include understanding what motivates health care professionals, financial and non-financial incentives in the health care sector, applied microeconometrics and labour economics.

    Read more

  • Martina Garau

    Martina Garau

    Senior Economist

    Martina’s current research includes economic issues posed by the development and provision of treatments for rare diseases; the economics of personalised medicine for health care payers and the pharmaceutical industry; and value-based assessment processes to determine pricing and reimbursement of health interventions, including diagnostics.

    Read more

  • Claire Devaney

    Claire Green

    Personal Assistant to the Directors

    Claire's key responsibility is time management and administrative support for the Directors.

    Read more

  • Grace Marsden

    Grace Marsden

    Health Economist

    Grace’s areas of expertise include cost utility analysis, cost effectiveness analysis and systematic reviews.

    Read more

  • Phill O'Neill

    Phill O’Neill

    Head of Information and Analysis

    Phill's research interests include the economics of the pharmaceutical market, the productivity and outputs of NICE, and benchmarking industry performance.

    Read more

  • Michele Pistollato

    Michele Pistollato


    Michele's research focuses on pharmaceuticals' life cycle pricing, with a particular focus on industrial competition, market structure, efficiency, and welfare in both a static and dynamic context.

    Read more

  • Olivia Reed

    Olivia Reed

    Data Analyst

    Olivia provides data collection and analysis for OHE's expanding portfolio of projects.

    Read more

  • Juan Rejón-Parrilla

    Juan Carlos Rejón-Parrilla

    Health Economist

    Juan Carlos’ research interests include economic issues arising from the development and implementation of personalised medicine and international approaches to health technology assessment.

    Read more

  • Sarah Karlsberg Schaffer

    Sarah Karlsberg Schaffer


    Sarah’s research interests include health policy evaluation, the economics of long-term care and cost-effectiveness thresholds in the NHS. Her interests also include investment decisions in the NHS and aspects of applied industrial organisation and labour economics.

    Read more

  • Koonal Shah

    Koonal Shah

    Senior Economist

    Koonal's current research interests include health state valuation and the use of social value judgements in health care decision making.

    Read more

  • Kerry Sheppard

    Kerry Sheppard

    Business Executive

    Kerry's responsibilities include maintaining the website, overseeing the production and publishing of in-house publications, organising events and serving as the contact point for accounts.

    Read more